Towards case-based performance measures: Uncovering deficiencies in applied medical care

Journal of Evaluation in Clinical Practice

Volumn 7, Issue 4, 2001, Pages 355-363

  Hoelzer, Simon ^a   Waechter, Werner ^a   Stewart, Andrew ^b   Liu, Raymond ^c   Schweiger, Ralf ^a   Dudeck, Joachim ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b AMERICAN COLLEGE OF SURGEONS   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Actual care; Case based measures; Information technology; Outcome; Performance measures; Population based measures; Variations of health care services

Indexed keywords

ARTICLE; HEALTH CARE DELIVERY; HEALTH SERVICE; INFORMATION SYSTEM; MEDICAL CARE; OUTCOMES RESEARCH; PATIENT CARE; PERFORMANCE; PRIORITY JOURNAL; TECHNOLOGY;

CASE-CONTROL STUDIES; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY INDICATORS, HEALTH CARE;

EID: 0035189570     PISSN: 13561294     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2753.2001.00297.x     Document Type: Article

References (46)

1. Concepts of GTDS: An oncology workstation
2. GTDS - A tool for tumor registries to support shared patient care
3. Integrating performance measure data into the Joint Commission accreditation process
4. An expanded view of risk-group definition in differentiated thyroid carcinoma
5. A national quality improvement effort: Cancer registry data
6. Survival discriminants for differentiated thyroid cancer
7. Does the method of management of papillary thyroid carcinoma make a difference in outcome?
8. Healthcare system performance indicators: A new beginning for a reformed Canadian healthcare system
9. Communication standards: Problems and future trends
10. Aspects of implementing and harmonizing healthcare communication standards
11. Performance measurement: Problems and solutions
12. Thyroid tumors
13. Hospital use of NCDB data to assess quality of cancer patient care
14. Defining and measuring health inequality: An approach based on the distribution of health expectancy
15. Are performance measures relevant?
16. Measuring quality of care with routine data: Avoiding confusion between performance indicators and health outcomes
17. National hospital discharge survey: Annual summary, 1994
18. Effect of clinical guidelines on medical practice: A systematic review of rigorous evaluations
19. Achieving health gain through clinical guidelines II: Ensuring guidelines change medical practice
20. Evidence-based implementation of evidence-based medicine
21. pTNM and residual tumor classifications: Problems of assessment and prognostic significance
22. Quality management in diagnosis and therapy of colorectal carcinoma
23. Tumors of the gastrointestinal tract and the pancreas: Histopathology, staging and prognosis
24. Prognostic factor research in oncology
25. Comparative study of oncological outcome quality in colorectal carcinoma - Ranking by surrogate endpoint?
26. The German experience: The surgeon as a prognostic factor in colon and rectal cancer surgery
27. Patient care evaluation studies: Applying this concept of quality management in oncology
28. Redesigning and adapting a concept of quality management in oncology
29. Patient care evaluation studies - A comprehensive concept for evaluation of oncologic patient management
30. Data warehousing as a tool for quality management in oncology
31. Effects of computer-based clinical decision support systems on physician performance and patient outcomes: A systematic review
32. Clinical highlights from the National Cancer Data Base: 1996
33. Impact of clinical trials on clinical practice: Example of thrombolysis for acute myocardial infarction
34. Differentiated thyroid cancer: Long-term impact of initial therapy
35. Papillary thyroid carcinoma: A 10 year follow-up report of the impact of therapy in 576 patients
36. Choosing and evaluating clinical performance measures
37. Developing a clinical performance measure
38. The growth and maturation of the National Cancer Data Base
39. The National Cancer Data Base report on longitudinal observations on prostate cancer
40. Development of WHO guidelines on generalized cost-effectiveness analysis
41. Health inequalities and social group differences: What should we measure?
42. Low-risk differentiated thyroid cancer: The need for selective treatment
43. Computer-based guideline implementation systems: A systematic review of functionality and effectiveness
44. A mechanism for assessment of patient care
45. Betablockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice